COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection
KeywordsCOVID-19, antibiotics, microbial resistance, Clostridium difficile
The development of Clostridium difficile infection in COVID-19 patients is an understudied complication of the disease. Herein, we present the case of a 46-year-old man who developed severe healthcare-associated C. difficile infection leading to toxic megacolon and perforation in the setting of COVID-19 infection. It is important to continue to follow guidelines regarding antibiotics in healthcare settings to prevent such complications.
Issue: 2021: Vol 8 No 8 (view)